| | | WEBINAR: Perceptions, Myths & New Thinking on Direct-to-Patient Clinical Supply | |
|
| | | Date: Thursday, January 23, 2020 Time: 8AM PST | 11AM EST | 4PM GMT |
|
| |
| | | | | Direct-to-patient distribution (DTP) of clinical supplies is an increasingly important tool for sponsors’ to be able to support recruitment and participation in their clinical studies.
This webinar will examine the results from a recent industry survey to evaluate just how important having a DTP option has become and sponsors’ understanding of the US regulatory requirements that must be satisfied in order to offer a DTP option.
In addition, common DTP misperceptions, perceived challenges and potential benefits will be discussed along with a streamlined approach that bypasses the clinic entirely. |
|
---|
| |
| | | Topics to be discussed include:
Sponsors perceived value of offering an DTP option including potential challenges and benefits Important regulatory considerations for DTP distribution in the US and Europe Review of DTP distribution models currently available to sponsors, including a streamlined, regulatory-compliant approach to bypass the clinical site |
|
| |
| | | | | | | Presenter: Nicole GrayDirector, Strategic Supply SolutionsCatalent Pharma Solutions |
|
---|
| |
| | | | | | To unsubscribe or manage your subscriptions, please click here. For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers. Catalent Pharma Solutions respects your privacy. Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content. | © 2019, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|